AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $304,000 | +130.3% | 862,168 | +367.4% | 0.00% | – |
Q1 2022 | $132,000 | -28.6% | 184,465 | +125.6% | 0.00% | – |
Q4 2021 | $185,000 | -11.9% | 81,774 | +12.4% | 0.00% | – |
Q3 2021 | $210,000 | +296.2% | 72,770 | +419.1% | 0.00% | – |
Q2 2021 | $53,000 | -60.2% | 14,019 | -64.3% | 0.00% | – |
Q1 2021 | $133,000 | -76.2% | 39,248 | -80.4% | 0.00% | -100.0% |
Q4 2020 | $560,000 | -39.3% | 200,093 | -45.5% | 0.00% | -50.0% |
Q3 2020 | $922,000 | -70.4% | 367,286 | +60.3% | 0.00% | -60.0% |
Q2 2020 | $3,111,000 | +89.0% | 229,059 | +5.5% | 0.01% | +66.7% |
Q1 2020 | $1,646,000 | -12.4% | 217,123 | -27.0% | 0.00% | +50.0% |
Q4 2019 | $1,880,000 | +434.1% | 297,479 | +231.4% | 0.00% | – |
Q3 2019 | $352,000 | +551.9% | 89,771 | +701.8% | 0.00% | – |
Q2 2019 | $54,000 | -75.0% | 11,196 | -50.5% | 0.00% | – |
Q1 2018 | $216,000 | -63.5% | 22,622 | -43.2% | 0.00% | -100.0% |
Q4 2017 | $592,000 | -41.7% | 39,831 | -22.8% | 0.00% | 0.0% |
Q3 2017 | $1,015,000 | – | 51,616 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |